Document is current
Any future updates will be listed below
-
Authors
Beukenhorst, Anna L.
Rice, Keira L.
Frallicciardi, Jacopo
Koldijk, Martin H.
Boudreau, Carolyn M.
Crawford, Justin
Cornelissen, Lisette A. H. M.
da Costa, Kelly A. S.
de Jong, Babette A.
Fischinger, Stephanie
Julg, Boris
Klap, Jaco M.
Koch, Clarissa M.
Magyarics, Zoltán
Mohamed, Faez A. Nait
Okonkwo, Vintus
Adams, Lindsey
McCarthy, Caitlin M.
Ronsard, Larance
Temperton, Nigel
Vietsch, Helene
Wichapong, Kanin
Ziere, Bertjan
Lingwood, Daniel
Goudsmit, Jaap
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 12 March 2025
First Online: 8 April 2025
Competing interests
: A.L.B., K.L.R., J.F., M.H.K, C.M.B., J.C., B.A.d.J., S.F., J.M.K., C.M.K., H.V., Z.M., and B.Z. disclose that they are employees of Leyden Laboratories with stock options in this company. B.J. is an advisor to Leyden Laboratories with stock options in this company; J.G. is an advisor to Leyden Laboratories with shares and stock options in this company. Other authors have not reported any conflicts of interest.
